Core Viewpoint - The recent trading data indicates a mixed performance for the Hong Kong Stock Connect Innovative Drug ETF, with slight net selling observed despite some financing buy-ins over the past few days [1] Group 1: Financing Activity - On August 4, the Hong Kong Stock Connect Innovative Drug ETF received a financing buy-in of 0.26 billion, ranking 1287th in the market [1] - Over the last three trading days (July 31 to August 4), the ETF saw financing buy-ins of 0.65 billion, 0.24 billion, and 0.26 billion respectively [1] - The financing repayment on August 4 amounted to 0.27 billion, resulting in a net selling of 22.03 thousand [1] Group 2: Short Selling Activity - On August 4, there were no shares sold short, resulting in a net short selling of 0.00 thousand shares [1]
港股通创新药ETF工银获融资买入0.26亿元，近三日累计买入1.16亿元
Jin Rong Jie·2025-08-05 01:09